Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity

J Rheumatol. 2005 Feb;32(2):287-91.

Abstract

Objective: To investigate serum levels of mannose-binding lectin (MBL), a complement-like protein of collectin family, in patients with Behcet's disease (BD).

Methods: MBL levels were measured in sera of 130 patients with BD, 64 patients with recurrent oral ulcerations (ROU), and 105 healthy controls (HC) with ELISA.

Results: Patients with BD had significantly lower median serum MBL levels compared to HC (1857 vs 3136 ng/ml, p = 0.001). No significant difference was observed in median serum MBL levels between BD and ROU (2309 ng/ml, p = 0.252). Low MBL levels (</= 500 ng/ml) were present in a higher proportion of BD patients compared to HC (29% vs 16%, p = 0.021). A severe disease course (total clinical severity score >/= 4) was more frequently observed in BD patients with very low serum MBL levels (</= 100 ng/ml) (19% vs 6%, p = 0.046). When serum MBL levels were analyzed separately according to gender, the frequency of vascular disease was higher in men with very low serum MBL levels (80% vs 42%, p = 0.042).

Conclusions: MBL deficiency might contribute to the pathogenesis of BD and affect its clinical course.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Behcet Syndrome / blood*
  • Behcet Syndrome / complications
  • Behcet Syndrome / pathology
  • Female
  • Humans
  • Male
  • Mannose-Binding Lectin / blood*
  • Middle Aged
  • Oral Ulcer / complications
  • Oral Ulcer / pathology
  • Severity of Illness Index*

Substances

  • Mannose-Binding Lectin